In the high-risk MSM group, there were more frequent findings of a history of HIV-positive sexual partners, sexually transmitted infections (STI), and heterozygosity for CCR5 Δ32 mutation compared with the low-risk MSM group. This evidence concerns the gene CCR5 and sexually transmitted disease.